Truncation of tau protein and its pathological significance in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 14, Issue 4, 2008, Pages 401-409

  García Sierra, Francisco ^a   Mondragón Rodríguez, Siddhartha ^a   Basurto Islas, Gustavo ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Alzheimer's disease; Apoptosis; Neurodegeneration; Neurofibrillary tangle; Tau aggregation

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CARBOXY TERMINAL SEQUENCE; CELL MATURATION; CONFORMATIONAL TRANSITION; DISEASE COURSE; HUMAN; IN VITRO STUDY; NEUROFIBRILLARY TANGLE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; REVIEW; TRANSGENIC MOUSE;

EID: 49149098756     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14407     Document Type: Review

References (107)

1. A. Abraha, N. Ghoshal, T.C. Gamblin, V. Cryns, R.W. Berry, J. Kuret and L.I. Binder, C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease, J Cell Sci 113(Pt 21) (2000), 3737-3745.
2. B. Allen, E. Ingram, M. Takao, M.J. Smith, R. Jakes, K. Virdee, H. Yoshida, M. Holzer, M. Craxton, P.C. Emson, C. Atzori, A. Migheli, R.A. Crowther, B. Ghetti, M.G. Spillantini and M. Goedert, Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein, J Neurosci 22 (2002), 9340-9351.
3. C. Alonso Adel, B. Li, I. Grundke-Iqbal and K. Iqbal, Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity, Proc Natl Acad Sci USA 103 (2006), 8864-8869.
4. A. Alzheimer, R.A. Stelzmann, H.N. Schnitzlein and F.R. Murtagh, An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde", Clin Anat 8 (1995), 429-431.
5. P.V. Arriagada, K. Marzloff and B.T. Hyman, Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease, Neurology 42 (1992), 1681-1688.
6. J. Avila, M. Perez, J.J. Lucas, A. Gomez-Ramos, I. Santa Maria, F. Moreno, M. Smith, G. Perry and F. Hernandez, Assembly in vitro of tau protein and its implications in Alzheimer's disease, Curr Alzheimer Res 1 (2004), 97-101.
7. J. Avila, Tau phosphorylation and aggregation in Alzheimer's disease pathology, FEBS Lett 580 (2006), 2922-2927.
8. C. Bancher, C. Brunner, H. Lassmann, H. Budka, K. Jellinger, G. Wiche, F. Seitelberger, I. Grundke-Iqbal, K. Iqbal and H.M. Wisniewski, Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease, Brain Res 477 (1989), 90-99.
9. B. Bandyopadhyay, G. Li, H. Yin and J. Kuret, Tau aggregation and toxicity in a cell culture model of tauopathy, J Biol Chem 282 (2007), 16454-16464.
10. G. Basurto-Islas, J. Luna-Muñoz, A.L. Guillozet-Bongaarts, L.I. Binder, R. Mena and F. García-Sierra, Accumulation of aspartic acid421- and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease, J Neuropathol Exp Neurol 67 (2008), 470-483.
11. R.W. Berry, A. Abraha, S. Lagalwar, N. LaPointe, T.C. Gamblin, V.L. Cryns and L.I. Binder, Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment, Biochemistry 42 (2003), 8325-8331.
12. L.M. Bierer, P.R. Hof, D.P. Purohit, L. Carlin, J. Schmeidler, K.L. Davis and D.P. Perl, Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease, Arch Neurol 52 (1995), 81-88.
13. J. Biernat, E.M. Mandelkow, C. Schroter, B. Lichtenberg-Kraag, B. Steiner, B. Berling, H. Meyer, M. Mercken, A. Vandermeeren, M. Goedert et al., The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region, Embo J 11 (1992), 1593-1597.
14. L.I. Binder, A.L. Guillozet-Bongaarts, F. Garcia-Sierra and R.W. Berry, Tau, tangles, and Alzheimer's disease, Biochim Biophys Acta 1739 (2005), 216-223.
15. C. Bjorkdahl, M.J. Sjogren, X. Zhou, H. Concha, J. Avila, B. Winblad and J.J. Pei, Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: Tau and neurofilaments, J Neurosci Res 86 (2007), 1343-1352.
16. W. Bondareff, C. Harrington, C.M. Wischik, D.L. Hauser and M. Roth, Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease, J Neuropathol Exp Neurol 53 (1994), 158-164.
17. H. Braak, E. Braak, I. Grundke-Iqbal and K. Iqbal, Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques, Neurosci Lett 65 (1986), 351-355.
18. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol (Berl) 82 (1991), 239-259.
19. N. Canu, L. Dus, C. Barbato, M.T. Ciotti, C. Brancolini, A.M. Rinaldi, M. Novak, A. Cattaneo, A. Bradbury and P. Calissano, Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis, J Neurosci 18 (1998), 7061-7074.
20. G. Carmel, E.M. Mager, L.I. Binder and J. Kuret, The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology, J Biol Chem 271 (1996), 32789-32795.
21. T. Casoli, G. Di Stefano, B. Giorgetti, M. Balietti, R. Recchioni, F. Moroni, F. Marcheselli, G. Bernardini, P. Fattoretti and C. Bertoni-Freddari, Platelet as a physiological model to investigate apoptotic mechanisms in Alzheimer beta-amyloid peptide production, Mech Ageing Dev 129 (2008), 154-162.
22. W. Chun and G.V. Johnson, Activation of glycogen synthase kinase 3beta promotes the intermolecular association of tau. The use of fluorescence resonance energy transfer microscopy, J Biol Chem 282 (2007), 23410-23417.
23. C.W. Chung, Y.H. Song, I.K. Kim, W.J. Yoon, B.R. Ryu, D.G. Jo, H.N. Woo, Y.K. Kwon, H.H. Kim, B.J. Gwag, I.H. Mook-Jung and Y.K. Jung, Proapoptotic effects of tau cleavage product generated by caspase-3, Neurobiol Dis 8 (2001), 162-172.
24. C.W. Cotman, W.W. Poon, R.A. Rissman and M. Blurton-Jones, The role of caspase cleavage of tau in Alzheimer disease neuropathology, J Neuropathol Exp Neurol 64 (2005), 104-112.
25. P. Delobel, I. Lavenir, G. Fraser, E. Ingram, M. Holzer, B. Ghetti, M.G. Spillantini, R.A. Crowther and M. Goedert, Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy, Am J Pathol 172 (2008), 123-131.
26. D.W. Dickson, H.A. Crystal, C. Bevona, W. Honer, I. Vincent and P. Davies, Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiol Aging 16 (1995), 285-298; discussion 298-304.
27. D.W. Dickson, Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? J Clin Invest 114 (2004), 23-27.
28. A. Ebneth, R. Godemann, K. Stamer, S. Illenberger, B. Trinczek and E. Mandelkow, Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease, J Cell Biol 143 (1998), 777-794.
29. T. Engel, F. Hernandez, J. Avila and J.J. Lucas, Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3, J Neurosci 26 (2006), 5083-5090.
30. T. Engel, J.J. Lucas, P. Gomez-Ramos, M.A. Moran, J. Avila and F. Hernandez, Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration, Neurobiol Aging 27 (2006), 1258-1268.
31. E. Falke, J. Nissanov, T.W. Mitchell, D.A. Bennett, J.Q. Trojanowski and S.E. Arnold, Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density, Am J Pathol 163 (2003), 1615-1621.
32. L. Fasulo, M. Ovecka, J. Kabat, A. Bradbury, M. Novak and A. Cattaneo, Overexpression of Alzheimer's PHF core tau fragments : implications for the tau truncation hypothesis., Alzheimers Res. 2 (1996), 195-200.
33. L. Fasulo, M. Visintin, M. Novak and A. Cattaneo, Tau truncation in Alzheimer's disease : expression of a fragment encompassing PHF core tau induces apoptosis in COS cells, Alzheimer's Rep. 1 (1998), 25-32.
34. L. Fasulo, G. Ugolini, M. Visintin, A. Bradbury, C. Brancolini, V. Verzillo, M. Novak and A. Cattaneo, The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis, J Neurochem 75 (2000), 624-633.
35. A. Ferrari, F. Hoerndli, T. Baechi, R.M. Nitsch and J. Gotz, beta-Amyloid induces paired helical filament-like tau filaments in tissue culture, J Biol Chem 278 (2003), 40162-40168.
36. P. Fischer, H. Lassmann, K. Jellinger, M. Simanyi, C. Bancher, A. Travniczek-Marterer, G. Gatterer and W. Danielczyk, [Alzheimer dementia. A clinical long-term study with quantitative neuropathology], Wien Med Wochenschr 141 (1991), 455-462.
37. M. Frasier, M. Walzer, L. McCarthy, D. Magnuson, J.M. Lee, C. Haas, P. Kahle and B. Wolozin, Tau phosphorylation increases in symptomatic mice overexpressing A30P alphasynuclein, Exp Neurol 192 (2005), 274-287.
38. T.A. Fulga, I. Elson-Schwab, V. Khurana, M.L. Steinhilb, T.L. Spires, B.T. Hyman and M.B. Feany, Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo, Nat Cell Biol 9 (2007), 139-148.
39. T.C. Gamblin, R.W. Berry and L.I. Binder, Tau polymerization: role of the amino terminus, Biochemistry 42 (2003), 2252-2257.
40. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. La-Pointe, R. Miller, R.W. Berry, L.I. Binder and V.L. Cryns, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc Natl Acad Sci U S A 100 (2003), 10032-10037.
41. F. Garcia-Sierra, J.J. Hauw, C. Duyckaerts, C.M. Wischik, J. Luna-Munoz and R. Mena, The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old, Acta Neuropathol (Berl) 100 (2000), 29-35.
42. F. Garcia-Sierra, C.M. Wischik, C.R. Harrington, J. Luna-Munoz and R. Mena, Accumulation of C-terminally truncated tau protein associated with vulnerability of the perforant pathway in early stages of neurofibrillary pathology in Alzheimer's disease, J Chem Neuroanat 22 (2001), 65-77.
43. F. Garcia-Sierra, N. Ghoshal, B. Quinn, R.W. Berry and L.I. Binder, Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease, J. Alzheimers Dis. 5 (2003), 65-77.
44. F. Garcia-Sierra, G. Basurto-Islas, I. Santa-Maria, R. Mena, J. Luna-Muñoz and L.I. Binder, Tau protein expressed in COS-7 cells displays similar phosphorylation and conformational changes as it occurs in Alzheimer's disease brains, FENS Forum (2008).
45. M.C. Gastard, J.C. Troncoso and V.E. Koliatsos, Caspase activation in the limbic cortex of subjects with early Alzheimer's disease, Ann Neurol 54 (2003), 393-398.
46. F.G. Gervais, D. Xu, G.S. Robertson, J.P. Vaillancourt, Y. Zhu, J. Huang, A. LeBlanc, D. Smith, M. Rigby, M.S. Shearman, E.E. Clarke, H. Zheng, L.H. Van Der Ploeg, S.C. Ruffolo, N.A. Thornberry, S. Xanthoudakis, R.J. Zamboni, S. Roy and D.W. Nicholson, Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation, Cell 97 (1999), 395-406.
47. N. Ghoshal, F. Garcia-Sierra, Y. Fu, L.A. Beckett, E.J. Mufson, J. Kuret, R.W. Berry and L.I. Binder, Tau-66: evidence for a novel tau conformation in Alzheimer's disease, J Neurochem 77 (2001), 1372-1385.
48. C.G. Glabe, Common mechanisms of amyloid oligomer pathogenesis in degenerative disease, Neurobiol Aging 27 (2006), 570-575.
49. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski and L.I. Binder, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc Natl Acad Sci U S A 83 (1986), 4913-4917.
50. A.L. Guillozet-Bongaarts, F. Garcia-Sierra, M.R. Reynolds, P.M. Horowitz, Y. Fu, T. Wang, M.E. Cahill, E.H. Bigio, R.W. Berry and L.I. Binder, Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease, Neurobiol Aging 26 (2005), 1015-1022.
51. H. Guo, S. Albrecht, M. Bourdeau, T. Petzke, C. Bergeron and A.C. LeBlanc, Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease, Am J Pathol 165 (2004), 523-531.
52. C.R. Harrington, E.B. Mukaetova-Ladinska, R. Hills, P.C. Edwards, E. Montejo de Garcini, M. Novak and C.M. Wischik, Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease, Proc Natl Acad Sci U S A 88 (1991), 5842-5846.
53. A.I. Iliev, S. Ganesan, G. Bunt and F.S. Wouters, Removal of pattern-breaking sequences in microtubule binding repeats produces instantaneous tau aggregation and toxicity, J Biol Chem 281 (2006), 37195-37204.
54. G.A. Jicha, A. O'Donnell, C. Weaver, R. Angeletti and P. Davies, Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase, J Neurochem 72 (1999), 214-224.
55. R. Katzman, R. Terry, R. DeTeresa, T. Brown, P. Davies, P. Fuld, X. Renbing and A. Peck, Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques, Ann Neurol 23 (1988), 138-144.
56. S. Keck, R. Nitsch, T. Grune and O. Ullrich, Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease, J Neurochem 85 (2003), 115-122.
57. I. Khlistunova, J. Biernat, Y. Wang, M. Pickhardt, M. von Bergen, Z. Gazova, E. Mandelkow and E.M. Mandelkow, Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs, J Biol Chem 281 (2006), 1205-1214.
58. K.S. Kosik, S. Bakalis, L. Galibert, D.J. Selkoe and L.K. Duffy, Age-related modifications of MAP-2, Ann N Y Acad Sci 466 (1986), 420-422.
59. J. Kuret, C.N. Chirita, E.E. Congdon, T. Kannanayakal, G. Li, M. Necula, H. Yin and Q. Zhong, Pathways of tau fibrillization, Biochim Biophys Acta 1739 (2005), 167-178.
60. J. Kuret, E.E. Congdon, G. Li, H. Yin, X. Yu and Q. Zhong, Evaluating triggers and enhancers of tau fibrillization, Microsc Res Tech 67 (2005), 141-155.
61. S. Le Corre, H.W. Klafki, N. Plesnila, G. Hubinger, A. Obermeier, H. Sahagun, B. Monse, P. Seneci, J. Lewis, J. Eriksen, C. Zehr, M. Yue, E. McGowan, D.W. Dickson, M. Hutton and H.M. Roder, An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice, Proc Natl Acad Sci U S A 103 (2006), 9673-9678.
62. V.M. Lee, B.J. Balin, L. Otvos, Jr. and J.Q. Trojanowski, A68: a major subunit of paired helical filaments and derivatized forms of normal Tau, Science 251 (1991), 675-678.
63. V.M. Lee, M. Goedert and J.Q. Trojanowski, Neurodegenerative tauopathies, Annu Rev Neurosci 24 (2001), 1121-1159.
64. H.L. Li, H.H. Wang, S.J. Liu, Y.Q. Deng, Y.J. Zhang, Q. Tian, X.C. Wang, X.Q. Chen, Y. Yang, J.Y. Zhang, Q. Wang, H. Xu, F.F. Liao and J.Z. Wang, Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration, Proc Natl Acad Sci U S A 104 (2007), 3591-3596.
65. J. Luna-Munoz, F. Garcia-Sierra, V. Falcon, I. Menendez, L. Chavez-Macias and R. Mena, Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease, J Alzheimers Dis 8 (2005), 29-41.
66. J. Luna-Munoz, L. Chavez-Macias, F. Garcia-Sierra and R. Mena, Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease, J Alzheimers Dis 12 (2007), 365-375.
67. M. Medina, E. Montejo de Garcini and J. Avila, The role of tau phosphorylation in transfected COS-1 cells, Mol Cell Biochem 148 (1995), 79-88.
68. R. Mena, P.C. Edwards, C.R. Harrington, E.B. Mukaetova-Ladinska and C.M. Wischik, Staging the pathological assembly of truncated tau protein into paired helical filaments in Alzheimer's disease, Acta Neuropathol (Berl) 91 (1996), 633-641.
69. M.P. Mingeot-Leclercq, L. Lins, M. Bensliman, F. Van Bambeke, P. Van Der Smissen, J. Peuvot, A. Schanck and R. Brasseur, Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus, Chem Phys Lipids 120 (2002), 57-74.
70. T. Miyasaka, A. Watanabe, Y. Saito, S. Murayama, D.M. Mann, M. Yamazaki, R. Ravid, M. Morishima-Kawashima, K. Nagashima and Y. Ihara, Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads, J Neuropathol Exp Neurol 64 (2005), 665-674.
71. M.M. Mocanu, A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, L. Zhou, G. Rune and E.M. Mandelkow, The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy, J Neurosci 28 (2008), 737-748.
72. S. Mondragon-Rodriguez, G. Basurto-Islas, I. Santa-Maria, R. Mena, L.I. Binder, J. Avila, M.A. Smith, G. Perry and F. Garcia-Sierra, Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease, Int J Exp Path (2008), in press.
73. S. Mondragon-Rodriguez, R. Mena, L.I. Binder, M.A. Smith, G. Perry and F. Garcia-Sierra, Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology, Neuropathol Appl Neurobiol 34 (2008), 62-75.
74. E. Montejo de Garcini, S. de la Luna, J.E. Dominguez and J. Avila, Overexpression of tau protein in COS-1 cells results in the stabilization of centrosome-independent microtubules and extension of cytoplasmic processes, Mol Cell Biochem 130 (1994), 187-196.
75. J.C. Morris, Classification of dementia and Alzheimer's disease, Acta Neurol Scand Suppl 165 (1996), 41-50.
76. E.B. Mukaetova-Ladinska, C.R. Harrington, M. Roth and C.M. Wischik, Biochemical and anatomical redistribution of tau protein in Alzheimer's disease, Am J Pathol 143 (1993), 565-578.
77. E.B. Mukaetova-Ladinska, F. Garcia-Siera, J. Hurt, H.J. Gertz, J.H. Xuereb, R. Hills, C. Brayne, F.A. Huppert, E.S. Paykel, M. McGee, R. Jakes, W.G. Honer, C.R. Harrington and C.M. Wischik, Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease, Am J Pathol 157 (2000), 623-636.
78. T.J. Nelson and D.L. Alkon, Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid, J Biol Chem 282 (2007), 31238-31249.
79. J. Newman, R.A. Rissman, F. Sarsoza, R.C. Kim, M. Dick, D.A. Bennett, C.W. Cotman, T.T. Rohn and E. Head, Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathology, Acta Neuropathol 110 (2005), 135-144.
80. G. Niewiadomska and M. Baksalerska-Pazera, Age-dependent changes in axonal transport and cellular distribution of Tau 1 in the rat basal forebrain neurons, Neuroreport 14 (2003), 1701-1706.
81. G. Niewiadomska, M. Baksalerska-Pazera and G. Riedel, Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats, Ann N Y Acad Sci 1048 (2005), 287-295.
82. M. Novak, R. Jakes, P.C. Edwards, C. Milstein and C.M. Wischik, Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51, Proc Natl Acad Sci U S A 88 (1991), 5837-5841.
83. M. Novak, J. Kabat and C.M. Wischik, Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament, Embo J 12 (1993), 365-370.
84. S.Y. Park, C. Tournell, R.C. Sinjoanu and A. Ferreira, Caspase-3- and calpain-mediated tau cleavage are differentially prevented by estrogen and testosterone in beta-amyloid-treated hippocampal neurons, Neuroscience 144 (2007), 119-127.
85. A.K. Raina, A. Hochman, X. Zhu, C.A. Rottkamp, A. Nunomura, S.L. Siedlak, H. Boux, R.J. Castellani, G. Perry and M.A. Smith, Abortive apoptosis in Alzheimer's disease, Acta Neuropathol (Berl) 101 (2001), 305-310.
86. E.M. Ribe, M. Perez, B. Puig, I. Gich, F. Lim, M. Cuadrado, T. Sesma, S. Catena, B. Sanchez, M. Nieto, P. Gomez-Ramos, M.A. Moran, F. Cabodevilla, L. Samaranch, L. Ortiz, A. Perez, I. Ferrer, J. Avila and T. Gomez-Isla, Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice, Neurobiol Dis 20 (2005), 814-822.
87. R.A. Rissman, W.W. Poon, M. Blurton-Jones, S. Oddo, R. Torp, M.P. Vitek, F.M. LaFerla, T.T. Rohn and C.W. Cotman, Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology, J Clin Invest 114 (2004), 121-130.
88. T.T. Rohn, E. Head, W.H. Nesse, C.W. Cotman and D.H. Cribbs, Activation of caspase-8 in the Alzheimer's disease brain, Neurobiol Dis 8 (2001), 1006-1016.
89. T.T. Rohn, E. Head, J.H. Su, A.J. Anderson, B.A. Bahr, C.W. Cotman and D.H. Cribbs, Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease, Am J Pathol 158 (2001), 189-198.
90. D.C. Rubinsztein, The roles of intracellular protein-degradation pathways in neurodegeneration, Nature 443 (2006), 780-786.
91. W.A. Samuel, V.W. Henderson and C.A. Miller, Severity of dementia in Alzheimer disease and neurofibrillary tangles in multiple brain regions, Alzheimer Dis Assoc Disord 5 (1991), 1-11.
92. I. Santa-Maria, M. Perez, F. Hernandez, V. Munoz, F.J. Moreno and J. Avila, In vitro tau fibrillization: mapping protein regions, Biochim Biophys Acta 1762 (2006), 683-692.
93. I. Santa-Maria, F. Hernandez, J. Del Rio, F.J. Moreno and J. Avila, Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau, Mol Neurodegener 2 (2007), 17.
94. M.A. Smith, A. Nunomura, H.G. Lee, X. Zhu, P.I. Moreira, J. Avila and G. Perry, Chronological primacy of oxidative stress in Alzheimer disease, Neurobiol Aging 26 (2005), 579-580.
95. M. Stefani and C.M. Dobson, Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution, J Mol Med 81 (2003), 678-699.
96. G.B. Stokin and L.S. Goldstein, Axonal transport and Alzheimer's disease, Annu Rev Biochem 75 (2006), 607-627.
97. J.H. Su, J.P. Kesslak, E. Head and C.W. Cotman, Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain, Acta Neuropathol 104 (2002), 1-6.
98. H. Takuma, T. Tomiyama, K. Kuida and H. Mori, Amyloid beta peptide-induced cerebral neuronal loss is mediated by caspase-3 in vivo, J Neuropathol Exp Neurol 63 (2004), 255-261.
99. D.M. Walsh and D.J. Selkoe, A beta oligomers - a decade of discovery, J Neurochem 101 (2007), 1172-1184.
100. Q. Wang, R.L. Woltjer, P.J. Cimino, C. Pan, K.S. Montine, J. Zhang and T.J. Montine, Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein, Faseb J 19 (2005), 869-871.
101. Y.P. Wang, J. Biernat, M. Pickhardt, E. Mandelkow and E.M. Mandelkow, Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model, Proc Natl Acad Sci U S A 104 (2007), 10252-10257.
102. A. Williams, L. Jahreiss, S. Sarkar, S. Saiki, F.M. Menzies, B. Ravikumar and D.C. Rubinsztein, Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications, Curr Top Dev Biol 76 (2006), 89-101.
103. C.M. Wischik, M. Novak, P.C. Edwards, A. Klug, W. Tichelaar and R.A. Crowther, Structural characterization of the core of the paired helical filament of Alzheimer disease, Proc Natl Acad Sci U S A 85 (1988), 4884-4888.
104. C.M. Wischik, M. Novak, H.C. Thogersen, P.C. Edwards, M.J. Runswick, R. Jakes, J.E. Walker, C. Milstein, M. Roth and A. Klug, Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease, Proc Natl Acad Sci U S A 85 (1988), 4506-4510.
105. C.M. Wischik, P.C. Edwards, R.Y. Lai, H.N. Gertz, J.H. Xuereb, E.S. Paykel, C. Brayne, F.A. Huppert, E.B. Mukaetova-Ladinska, R. Mena and et al., Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease, Neurobiol Aging 16 (1995), 409-417; discussion 418-431.
106. C.W. Wittmann, M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, M. Hutton and M.B. Feany, Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles, Science 293 (2001), 711-714.
107. X. Zhu, H.G. Lee, G. Casadesus, J. Avila, K. Drew, G. Perry and M.A. Smith, Oxidative imbalance in Alzheimer's disease, Mol Neurobiol 31 (2005), 205-217.